Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002929576 | SCV003661921 | uncertain significance | Inborn genetic diseases | 2022-11-18 | criteria provided, single submitter | clinical testing | The c.5452A>G (p.N1818D) alteration is located in exon 42 (coding exon 41) of the CDH23 gene. This alteration results from a A to G substitution at nucleotide position 5452, causing the asparagine (N) at amino acid position 1818 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |